Ultragenyx Pharmaceutical
RARE · NASDAQ
Bulios Fair Price
$19.02
31.2% upside
Trenutna cena
$14.5
Po podatkih Bulios Fair Price je delnica RARE trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Ultragenyx Pharmaceutical is a biotechnology company focused on developing innovative therapeutic options for rare genetic diseases. The company specializes in developing drugs that target specific genetic mutations or metabolic pathways that cause various rare diseases, including genetic disorders that affect metabolism, growth, and development. Ultragenyx focuses on conditions for which there are limited available treatment options and strives to improve the lives of patients with these diseases.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Emil D. Kakkis
Employees
1,371
Headquarters
Novato
Prihajajoči dogodki
Earnings
Upcoming earnings report